Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,000,000
+9,000 (0.91%)
At close: May 13, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Contract Development and Manufacturing Organization (CDMO)
3,009.62B
Log In
Log In
Log In
Log In
Contract Development and Manufacturing Organization (CDMO) Growth
12.54%
Log In
Log In
Log In
Log In
Biopharmaceutical Development and Commercialization
1,537.70B
Log In
Log In
Log In
Log In
Biopharmaceutical Development and Commercialization Growth
50.71%
Log In
Log In
Log In
Log In
Product
4,165.07B
Log In
Log In
Log In
Log In
Product Growth
22.39%
Log In
Log In
Log In
Log In
Other
382.25B
Log In
Log In
Log In
Log In
Other Growth
31.09%
Log In
Log In
Log In
Log In

EBIT by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Contract Development and Manufacturing Organization (CDMO) Operating Profit
1,119.36B
Log In
Log In
Log In
Log In
Contract Development and Manufacturing Organization (CDMO) Operating Profit Growth
2.86%
Log In
Log In
Log In
Log In
Biopharmaceutical Development and Commercialization Operating Profit
200.69B
Log In
Log In
Log In
Log In
Biopharmaceutical Development and Commercialization Operating Profit Growth
688.23%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Domestic
135.18B
Log In
Log In
Log In
Log In
Domestic Growth
17.99%
Log In
Log In
Log In
Log In
Europe
2,963.25B
Log In
Log In
Log In
Log In
Europe Growth
25.89%
Log In
Log In
Log In
Log In
USA
1,174.14B
Log In
Log In
Log In
Log In
USA Growth
20.91%
Log In
Log In
Log In
Log In
Other Geographic
274.75B
Log In
Log In
Log In
Log In
Other Geographic Growth
7.69%
Log In
Log In
Log In
Log In